Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 12, 2025 • 9:31 AM ET

Date/Time Source News Release
04/16/2025 08:00 AM EDT GlobeNewswire Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Appoints Renowned MIT Professor Robert S. Langer to its Scientific Advisory Board
03/26/2025 08:00 AM EDT GlobeNewswire Salarius Pharmaceuticals Merger Partner, Decoy Therapeutics, Announces its Novel Inhibitors Show Promising In Silico Activity Against Measles and Related Viruses
03/24/2025 08:00 AM EDT GlobeNewswire Salarius Pharmaceuticals Reports 2024 Financial Results and Provides Business Update
02/03/2025 08:00 AM EST GlobeNewswire Salarius Pharmaceuticals Announces Patient Enrollment to Resume in Investigator-initiated Phase 1/2 Clinical Trial Using Seclidemstat with Azacitidine to Treat Hematologic Cancers
01/13/2025 08:00 AM EST GlobeNewswire Salarius Pharmaceuticals and Decoy Therapeutics Announce Definitive Merger Agreement
06/17/2024 08:00 AM EDT GlobeNewswire Clinical Data on Salarius Pharmaceuticals' Seclidemstat in Patients with MDS and CMML Presented at the 2024 European Hematology Association Annual Meeting
06/12/2024 08:00 AM EDT GlobeNewswire Salarius Pharmaceuticals Announces 1-for-8 Reverse Stock Split
03/22/2024 04:05 PM EDT GlobeNewswire Salarius Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
01/16/2024 08:00 AM EST GlobeNewswire Salarius Pharmaceuticals Issued U.S. Patent for Next-Generation Targeted Protein Degraders
01/03/2024 08:30 AM EST GlobeNewswire Investigator-initiated Phase 1/2 Clinical Trial Using Salarius Pharmaceuticals' Seclidemstat in Combination with Azacitidine to Treat Hematologic Cancers Resumes Patient Enrollment
Page

Additional News

As of June 12, 2025 • 9:31 AM ET

Date/Time Source News Release
05/12/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Monday, May 12th, 2025
05/12/2025 05:31 AM EDT US Earnings Reports Expected earnings - Salarius Pharmaceuticals Inc.
03/24/2025 08:09 AM EDT SeekingAlpha Salarius Pharmaceuticals GAAP EPS of -$5.79
01/13/2025 01:23 PM EST 24/7 Market News These are some of the Hot Stocks Traders are Buying Today: PHIO, SLRX, SAGE, and LITM
01/13/2025 01:15 PM EST SeekingAlpha Salarius Pharmaceuticals and Decoy Therapeutics announce merger
11/27/2024 04:31 AM EST US Earnings Reports Expected earnings - Salarius Pharmaceuticals Inc.
11/20/2024 05:38 AM EST SeekingAlpha Warning: SLRX is at high risk of performing badly
07/25/2024 04:30 PM EDT QM US Market Movers News US Companies Moving the Markets, Evening edition
Thu, Jul 25, 2024 as of 4:00 pm ET
07/25/2024 11:23 AM EDT InvestorBrandNetwork Salarius Pharmaceuticals Inc. (NASDAQ: SLRX) Near the Top of Equities by Percentage Gain on 7/25
07/25/2024 10:00 AM EDT QM US Market Movers News US Companies Moving the Markets, Morning edition
Thu, Jul 25, 2024 as of 10.00 am ET
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.